SCHEMBL556967

SCHEMBL556967

CCOC(=S)SCC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
CYP2D6 P10635 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.50
MAPK1 P28482 1/20 0.50
CDC25B P30305 1/20 0.49
HDAC3 O15379 2/20 0.48
HDAC4 P56524 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
KMT2A Q03164 3/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 2/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865008 0.79 ALDH1A1 (0.70) ALDH1A1CYP2D6L3MBTL1HDAC3HDAC4
SCHEMBL21307662 0.77 HDAC3 (0.71) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL13680173 0.76 ALDH1A1 (0.61) ALDH1A1L3MBTL1MAPK1CDC25BKMT2A
SCHEMBL1557559 0.76 ALDH1A1 (0.61) ALDH1A1L3MBTL1MAPK1KMT2ALMNA
SCHEMBL264585 0.76 CA12 (0.52) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL27493267 0.76 ALDH1A1 (0.61) ALDH1A1L3MBTL1MAPK1KMT2AMAPT
SCHEMBL18123060 0.76 ALDH1A1 (0.53) ALDH1A1CYP2D6L3MBTL1MAPK1CDC25B
SCHEMBL11613274 0.76 ALDH1A1 (0.66) ALDH1A1L3MBTL1MAPK1CDC25BKMT2A
SCHEMBL5702002 0.74 ALDH1A1 (0.46) ALDH1A1CYP2D6L3MBTL1HDAC3HDAC4
SCHEMBL8337268 0.74 PPID (0.58) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2417151-B1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY UNIV GRENOBLE 1 (FR) 2016-09-14 EP disclosed
EP-2417151-B1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY UNIV GRENOBLE 1 (FR) 2016-09-14 EP disclosed
US-9133237-B2 Cyclic peptides with an anti-parasitic activity UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2015-09-15 US disclosed
US-9133237-B2 Cyclic peptides with an anti-parasitic activity UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2015-09-15 US disclosed
US-9133237-B2 Cyclic peptides with an anti-parasitic activity UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2015-09-15 US disclosed
EP-2417151-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY Universite Joseph Fourier (Grenoble 1) (FR) 2012-02-15 EP disclosed
US-20120034593-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-02-09 US disclosed
US-20120034593-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-02-09 US disclosed
US-20120034593-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-02-09 US disclosed
WO-2010116085-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2010-10-14 WO disclosed
WO-2010116085-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034593-A1 CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY VIP, NGLY1, QPCT ALDH1A1 4453/4885CYP2D6 4293/4885L3MBTL1 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.